⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 27, 2006ThoraxOpen Access

Is EGFR expression important in non-small cell lung cancer?

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

There are still many unanswered questions on the use of EGFR treatment in NSCLC

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Siow Ming Lee (2006) studied this question.

synapsesocial.com/papers/6a94ea1fd002db7cabf57be3 https://doi.org/10.1136/thx.2005.047936

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysisPrognostic Study · 2005 · 135 citations
2Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung CancerRCT · 2003 · 2,541 citations
3Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on PrognosisPrognostic Study · 2003 · 1,496 citations
4<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to GefitinibOriginal Research · 2005 · 3,989 citations
5Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibOriginal Research · 2004 · 11,599 citations